DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Stake Decreased by Sasco Capital Inc. CT

Sasco Capital Inc. CT lessened its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 14.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 854,940 shares of the medical instruments supplier’s stock after selling 141,500 shares during the period. DENTSPLY SIRONA comprises about 3.5% of Sasco Capital Inc. CT’s holdings, making the stock its 8th biggest position. Sasco Capital Inc. CT owned about 0.42% of DENTSPLY SIRONA worth $23,135,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. UMB Bank n.a. raised its holdings in DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after acquiring an additional 753 shares during the period. Capital Performance Advisors LLP bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $27,000. LRI Investments LLC lifted its holdings in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares in the last quarter. Rothschild Investment LLC bought a new position in DENTSPLY SIRONA in the 2nd quarter worth about $32,000. Finally, Kennebec Savings Bank purchased a new position in DENTSPLY SIRONA during the 3rd quarter valued at about $35,000. Institutional investors own 95.70% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on XRAY. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research dropped their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Finally, Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $18.46 on Tuesday. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $37.60. The business’s fifty day moving average price is $23.92 and its 200-day moving average price is $25.38. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of -8.92, a PEG ratio of 1.80 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the prior year, the company earned $0.49 earnings per share. The firm’s revenue was up .4% on a year-over-year basis. On average, equities analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.